Interpace Biosciences, Inc. (IDXG): R&D Expense
$642.0K
Year ended 2025-12-31
$593.0K
Trailing 12 months to 2026-06-30
-3.0%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $642.0K | -5.0% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $676.0K | +6.3% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $636.0K | -9.5% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $703.0K | -52.9% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $1.49M | n/c | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $2.79M | -0.5% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $2.81M | +32.3% | 2021-04-01, From 2019-01-01 |
| 2018-12-31 | $2.12M | +45.4% | 2021-01-19, From 2018-01-01 |
| 2017-12-31 | $1.46M | -11.3% | 2019-03-21, From 2017-01-01 |
| 2016-12-31 | $1.65M | -28.1% | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | $2.29M | +798.8% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $255.0K | n/a | 2016-03-30, From 2014-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $642.0K | -5.0% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $668.0K | -17.8% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $675.6K | +0.2% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $13.90M | +12.1% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $4.39M | -16.6% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $3.69M | +47.9% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $1.35M | +101.0% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $58.19M | +35.9% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $14.96M | -15.4% |
Compare IDXG, UTMD, RVP, CLPT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗